BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26683406)

  • 1. Active Surveillance for Ductal Carcinoma in Situ: Shining Light Into the Modeling Abyss.
    Etzioni R; Gulati R
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26683406
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
    Ryser MD; Worni M; Turner EL; Marks JR; Durrett R; Hwang ES
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26683405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
    J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of ductal carcinoma in situ and subsequent interval cancers.
    Shieh Y; Eklund M; Esserman L
    BMJ; 2016 Feb; 352():i551. PubMed ID: 26834245
    [No Abstract]   [Full Text] [Related]  

  • 5. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
    Barratt A
    BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
    [No Abstract]   [Full Text] [Related]  

  • 6. DCIS and invasive interval breast cancer.
    Foucar E
    Lancet Oncol; 2016 Mar; 17(3):e87. PubMed ID: 26972860
    [No Abstract]   [Full Text] [Related]  

  • 7. DCIS and invasive interval breast cancer.
    Narod SA; Sopik V; Sun P
    Lancet Oncol; 2016 Mar; 17(3):e87-e88. PubMed ID: 26972859
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of DCIS and reduced invasive interval cancers.
    Evans A
    Lancet Oncol; 2016 Jan; 17(1):14-5. PubMed ID: 26655426
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for early breast cancer reduces invasive cancer, study finds.
    Mayor S
    BMJ; 2015 Dec; 351():h6576. PubMed ID: 26643040
    [No Abstract]   [Full Text] [Related]  

  • 10. DCIS and invasive interval breast cancer - Author's reply.
    Duffy SW
    Lancet Oncol; 2016 Mar; 17(3):e88-e89. PubMed ID: 26972861
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
    Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
    Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Untreated Screening-Detected Breast Cancer: An Argument Against Delaying Screening or Increasing the Interval Between Screenings.
    Arleo EK; Monticciolo DL; Monsees B; McGinty G; Sickles EA
    J Am Coll Radiol; 2017 Jul; 14(7):863-867. PubMed ID: 28457814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the Effectiveness of Mammography.
    Chen WY
    JAMA Oncol; 2015 Nov; 1(8):1037-8. PubMed ID: 26501739
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening mammography after autologous breast reconstruction is not beneficial.
    Barton MK
    CA Cancer J Clin; 2015; 65(1):3-4. PubMed ID: 25533748
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing Mammography Screening Intervals.
    Yi M; Hunt KK
    JAMA; 2015 Oct; 314(15):1635-6. PubMed ID: 26501538
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.